Skip to content

The effects of body weight support, guidance, and gait speed on the patterning of muscle activity in the Lokomat, in children with Cerebral Palsy.

The effects of body weight support, guidance, and gait speed on the patterning of muscle activity in the Lokomat, in children with Cerebral Palsy. - Patterning of muscle activity in the Lokomat in children with CP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45091
Enrollment
20
Registered
2014-12-22
Start date
2014-10-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

Participants from both groups will be assessed on the treadmill, both during walking in the Lokomat exoskeleton, as well as outside the exoskeleton. During walking in the Lokomat, the following para

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children with Cerebral Palsy: 1. Age 6-16 2. A Gross Motor Function Classification System score of I (only children with walking disabilities and, as such, receive gait training) and II -IV 3. Femur length between 0.21-0.47m 4. Ability to walk independently with the aid of parallel bars 5. Ability to signal fear, pain or discomfort 6. Compliance and ability to follow simple instructions 7. Children should meet the general requirements for the training with the driven gait orthosis Lokomat (Hocoma AG, Volketswil, Switzerland);Healthy walkers: 1. Age 6-16

Exclusion criteria

Exclusion criteria: Children with CP: 1. Co-morbidity that can affect the results of the study (e.g. pre-existent problems in leg function or a progressive neurological disorder). 2. Treatment with botulinum toxin during the previous six months. 3. Orthopaedic of neurological surgery during the previous year. 4. Unstable epilepsy (*2 attacks/week). 5. Participation in other scientific studies at the moment of measurement.;Healthy walkers: The participant doesn*t suffer from neurological, orthopedic, visual, somatosensory or vestibular disorders, or any other disorder that is known to affect gait behavior or muscle activity.

Design outcomes

Primary

MeasureTime frame
The amplitude of muscle activity in µvolts.

Secondary

MeasureTime frame
Not Applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)